vimarsana.com

Latest Breaking News On - Stelis biopharma limited - Page 1 : vimarsana.com

Syngene to acquire multi-modal facility from Stelis Biopharma for Rs 702 Cr

Adding 20,000 liters of installed biologics drug substance manufacturing capacity

Jonathan huntStelis biopharma limitedManaging director

Stocks to Watch: LTIMindtree, SBI, RBL Bank, Bandhan Bank, Lupin, AU SFB, and Others

Stocks to watch: Shares of firms like LTIMindtree, SBI, RBL Bank, Bandhan Bank, Lupin, AU SFBs, and others will be in focus on Wednesday's trade.

Aurobindo pharmaSunil samdaniViiv healthcare companyLemon tree hotelsPrysm systems incSamvardhana motherson internationalSygene internationalTechnology gmbh switzerlandBandhan bankNifty financial servicesHousing development finance corporationCommittee of the central boardStelis biopharma limitedCurateq biologics privateYachiyo industry coAu small finance bank

Syngene to acquire Unit 3 biologics manufacturing site for gross value of ₹702 cr

Syngene to acquire Unit 3 biologics manufacturing site for gross value of ₹702 cr
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Jonathan huntSibaji biswasStelis biopharma limitedManaging director

Stocks to Watch today, July 5: LTIMindtree, Bandhan Bk, Lupin, Adani Power

Stocks to Watch on Wednesday, July 5: LTIMindtree will replace HDFC in the benchmark Nifty50 index, while LIC Housing Finance will likely replace it in the Nifty Financial Services index

Tamil naduSouth koreaAurobindo pharmaSunil samdaniViiv healthcare companyMacrotech developers onNifty financial servicesSygene internationalCurateq biologics privateMacrotech developersYachiyo industry coAu small finance bankPrysm systems incTechnology gmbh switzerlandFirst energyHousing development finance corporation

Strides Pharma Science biologics arm to divest Unit 3 multi modal facility to Syngene International for Rs 702 crore

Bengaluru: Stelis Biopharma Limited, an emerging biopharmaceutical Contract Development and Manufacturing Organization (CDMO) and the biologics arm of Strides Pharma Science Limited, has announced.

Strides pharma scienceStelis biopharmaManufacturing organizationContract developmentSyngene internationalStelis biopharma limitedStrides pharma science limitedSyngene international limitedBommasandra industrial area

vimarsana © 2020. All Rights Reserved.